Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cancer care at home: a new study tests if shots are better than clinic visits

NCT ID NCT06265285

First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 35 times

Summary

This study looks at whether giving the cancer drug nivolumab as a shot at home is as good as getting it in a clinic. It aims to reduce the time, cost, and stress of traveling for treatment. About 50 adults with various advanced cancers will try both settings and report which they prefer and how it affects their quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mayo Clinic in Florida

    RECRUITING

    Jacksonville, Florida, 32224-9980, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

bladder transitional cell carcinoma cancer carcinoma of esophagus colorectal cancer colorectal carcinoma colorectal neoplasm cutaneous melanoma Esophageal Neoplasms esophageal squamous cell carcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma hepatocellular carcinoma melanoma metastatic melanoma non-small cell lung carcinoma renal cell adenocarcinoma renal cell carcinoma skin squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck transitional cell carcinoma urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA ADVANCED RENAL CELL CARCINOMA CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE IIB CUTANEOUS MELANOMA AJCC V8 CLINICAL STAGE IIB CUTANEOUS MELANOMA AJCC V8 CLINICAL STAGE IIC CUTANEOUS MELANOMA AJCC V8 CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8 CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8 CLINICAL STAGE III ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE III ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE IV CUTANEOUS MELANOMA AJCC V8 CLINICAL STAGE IV CUTANEOUS MELANOMA AJCC V8 CLINICAL STAGE IV ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 CLINICAL STAGE IV ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 ESOPHAGEAL CARCINOMA GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA HEPATOCELLULAR CARCINOMA LOCALLY ADVANCED UROTHELIAL CARCINOMA LUNG NON-SMALL CELL CARCINOMA MALIGNANT SOLID NEOPLASM METASTATIC COLORECTAL CARCINOMA METASTATIC CUTANEOUS MELANOMA METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC HEAD-AND-NECK SQUAMOUS-CELL CARCINOMA METASTATIC UROTHELIAL CARCINOMA RECURRENT ESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA RENAL CELL CARCINOMA STAGE III RENAL CELL CANCER AJCC V8 STAGE III RENAL CELL CANCER AJCC V8 STAGE IV COLORECTAL CANCER AJCC V8 STAGE IV COLORECTAL CANCER AJCC V8 STAGE IV CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK AJCC V8 STAGE IV CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK AJCC V8 STAGE IV RENAL CELL CANCER AJCC V8 STAGE IV RENAL CELL CANCER AJCC V8 UNRESECTABLE CUTANEOUS MELANOMA UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA UNRESECTABLE UROTHELIAL CARCINOMA UROTHELIAL CARCINOMA